scholarly journals Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets

2010 ◽  
Vol 104 (11) ◽  
pp. 1688-1695 ◽  
Author(s):  
Tomoji Ono ◽  
Michiaki Murakoshi ◽  
Noriyuki Suzuki ◽  
Norio Iida ◽  
Motoyasu Ohdera ◽  
...  
Keyword(s):  
Abdominal Obesity ◽  
Visceral Fat ◽  
Subcutaneous Fat ◽  
Japanese Men ◽  
Men And Women ◽  
Fat Accumulation ◽  
Visceral Fat Accumulation ◽  
The Metabolic Syndrome ◽  
Computed Tomography Images ◽  
Enteric Coated

Lactoferrin (LF), a multifunctional glycoprotein in mammalian milk, is reported to exert a modulatory effect on lipid metabolism. The aim of the present study was to elucidate whether enteric-coated LF (eLF) might improve visceral fat-type obesity, an underlying cause of the metabolic syndrome. Using a double-blind, placebo-controlled design, Japanese men and women (n26; aged 22–60 years) with abdominal obesity (BMI>25 kg/m2, and visceral fat area (VFA)>100 cm2) consumed eLF (300 mg/d as bovine LF) or placebo tablets for 8 weeks. Measurement of the total fat area, VFA and subcutaneous fat area from computed tomography images revealed a significant reduction in VFA ( − 14·6 cm2) in the eLF group, as compared with the placebo controls ( − 1·8 cm2;P = 0·009 by ANCOVA). Decreases in body weight, BMI and hip circumference in the eLF group ( − 1·5 kg, − 0·6 kg/m2, − 2·6 cm) were also found to be significantly greater than with the placebo (+1·0 kg, +0·3 kg/m2, − 0·2 cm;P = 0·032, 0·013, 0·041, respectively). There was also a tendency for a reduction in waist circumference in the eLF group ( − 4·4 cm) as compared with the placebo group ( − 0·9 cm;P = 0·073). No adverse effects of the eLF treatment were found with regard to blood lipid or biochemical parameters. From these results, eLF appears to be a promising agent for the control of visceral fat accumulation.

Fatty Liver Is a Better Marker of Muscle Insulin Resistance than Visceral Fat Accumulation in Nonobese Japanese Men

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1854-P
Author(s):  
SATOSHI KADOWAKI ◽  
YOSHIFUMI TAMURA ◽  
YUKI SOMEYA ◽  
KAGEUMI TAKENO ◽  
TAKASHI FUNAYAMA ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Fatty Liver ◽  
Visceral Fat ◽  
Japanese Men ◽  
Muscle Insulin Resistance ◽  
Fat Accumulation ◽  
Visceral Fat Accumulation

Visceral fat accumulation in obese subjects: relation to energy expenditure and response to weight loss

1992 ◽  
Vol 263 (5) ◽  
pp. E913-E919 ◽  
Author(s):  
R. Leenen ◽  
K. van der Kooy ◽  
P. Deurenberg ◽  
J. C. Seidell ◽  
J. A. Weststrate ◽  
...  
Keyword(s):  
Weight Loss ◽  
Energy Expenditure ◽  
Visceral Fat ◽  
Resting Metabolic Rate ◽  
Subcutaneous Fat ◽  
Premenopausal Women ◽  
Energy Deficit ◽  
Fat Accumulation ◽  
Visceral Fat Accumulation ◽  
Obese Subjects

Seventy-eight healthy obese subjects, 40 premenopausal women and 38 men aged 27-51 yr received a 4.2 MJ/day energy-deficit diet for 13 wk. Resting metabolic rate (RMR) and diet-induced thermogenesis (DIT) were measured by indirect calorimetry. Abdominal subcutaneous and visceral fat areas were calculated from magnetic resonance imaging scans before and after weight loss. Before weight loss, visceral fat accumulation was positively correlated with higher levels of RMR (P < 0.05) and DIT (P < 0.01) in women but not in men. The mean weight reduction was 12.2 +/- 3.5 (SD) kg. In men but not in women, an initially large visceral fat depot was associated with a reduced loss of weight and total fat mass (P < 0.05). Within each sex, an initial abundance of visceral fat was significantly related to a larger loss of visceral fat (P < 0.001) and in men to a smaller loss of subcutaneous fat (P < 0.05). These results suggest that there may be gender differences in the associations between visceral fat accumulation and components of energy expenditure (RMR and DIT) in obese subjects. Obese subjects with an initial abundance of visceral fat do not lose more body weight but more visceral fat than subjects with less visceral fat.

scholarly journals Visceral Fat Accumulation Is an Important Determinant of PAI-1 Levels in Young, Nonobese Men and Women

1998 ◽  
Vol 18 (11) ◽  
pp. 1716-1722 ◽  
Author(s):  
E. J. Giltay ◽  
J. M. H. Elbers ◽  
L. J. G. Gooren ◽  
J. J. Emeis ◽  
T. Kooistra ◽  
...  
Keyword(s):  
Visceral Fat ◽  
Important Determinant ◽  
Men And Women ◽  
Fat Accumulation ◽  
Visceral Fat Accumulation ◽  
Pai 1

scholarly journals Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome

2011 ◽  
Vol 107 (10) ◽  
pp. 1429-1434 ◽  
Author(s):  
Jinjin Chen ◽  
Ren Wang ◽  
Xiao-Fang Li ◽  
Rui-Liang Wang
Keyword(s):  
Metabolic Syndrome ◽  
Insulin Sensitivity ◽  
Visceral Fat ◽  
The Other ◽  
Standard Diet ◽  
Fat Pad ◽  
Bifidobacterium Adolescentis ◽  
Fat Accumulation ◽  
Visceral Fat Accumulation ◽  
The Metabolic Syndrome

The aim of the present study was to investigate the effects of Bifidobacterium adolescentis (Bif) supplementation on visceral fat accumulation and insulin sensitivity of the metabolic syndrome in HF-diet-fed rats. Adult male Wistar rats (n 10 per group) were fed four different experimental diets for 12 weeks as follows: standard diet; high-fat (HF) diet; a mix of HF diet and Bif; a mix of standard diet and Bif. Liver, mesenteric fat, epididymal fat, retroperitoneal fat, and inguinal fat, pancreas and triceps surae in all four groups of the rats were weighed, while liver steatosis and insulin sensitivity were evaluated at the end point of the study. As the number of intestinal Bifidobacterium species decreased obviously, fat pad weight and body weight increased significantly in the HF group compared with in the other three groups (P <0·05). Addition of Bif led to a reduction in body weight and fat pad weight (P <0·05). With an increase in liver weight, more severe steatosis of hepatocytes was observed in the HF group compared with in the other three groups. A significant decrease of the glucose infusion rate and pancreas weight was found in the HF group (P <0·05). This deleterious effect was alleviated when Bif was added to the diets. Bifidobacterium supplementation ameliorated visceral fat accumulation and insulin sensitivity of the metabolic syndrome in HF-diet-fed rats.

Sign in / Sign up

Export Citation Format

Share Document